Early-phase clinical trials, known as human pharmacology studies, start principally with the aim of collecting information on the safety and tolerability of the drug product. Dr. Arash Ghalamkarpour at SGS Life Sciences outlines why scientifically sound bridges should be established to link human pharmacology studies to initial exploratory studies and later confirmatory studies.